-
NICE and CDA Assessment of Artificial Intelligence-Enabled Health Technologies: Analysis and Insights
Sep 9, 2025, 16:22 PM -
Evaluating the Costs of Perioperative Iron-Deficiency Anemia Management in China: A Comparison of Ferric Derisomaltose, Ferric Carboxymaltose, and Usual Care
Sep 9, 2025, 16:22 PM -
An Evaluation of the Cost of Treatment for Low-Back Pain Among Patients Attending Public Healthcare Facilities in Nigeria
Sep 9, 2025, 16:22 PM -
The Impact of Dietary Supplements (Vitamin B12, Vitamin D, Magnesium) on the Quality of Life (QoL) of Users in Edessa, Northern Greece
Sep 9, 2025, 16:22 PM -
Early Life Hypoglycemia and Neurological Sequalae in Children With Congenital Hyperinsulinism
Sep 9, 2025, 16:22 PM -
Testing Automated-Prompt Engineering Strategies for Systematic Literature Review Screening
Sep 9, 2025, 16:22 PM -
AI-Enabled Extraction of eGFR and BRAF Testing Patterns in Advanced NSCLC: IMPACT-NSCLC, a Multicenter Real-World Study (2019-2024)
Sep 9, 2025, 16:22 PM -
Has the IRA Impacted International Price Differentials? Comparing US and German Drug Prices in the Era of MFP
Sep 9, 2025, 16:22 PM -
Trends and Scope of Japan’s Across-the-Board Pharmaceutical Price Revisions in FY2021-25
Sep 9, 2025, 16:22 PM -
Garbage In, Garbage Out: Can AI Reduce the Impact of Human Error in eCOA Localized Text Migration?
Sep 9, 2025, 16:22 PM -
Evaluating a Deep Learning Model for Classifying Pediatric Pneumonia in Israel
Sep 9, 2025, 16:22 PM -
Herpes Zoster Hospitalization Rates in Germany: A Retrospective Database Analysis
Sep 9, 2025, 16:22 PM -
Improving Patient Involvement in Cancer Clinical Trials: Development of Plain Language Checklists Within the SISAQOL-IMI Initiative
Sep 9, 2025, 16:22 PM -
A Comparative Analysis of Reimbursement Decisions for Targeted Therapies and Immunotherapies in NSCLC Across EU HTA Bodies
Sep 9, 2025, 16:22 PM -
Development of a Discrete Choice Experiment to Explore Preferences for Self-Sampling in a National UK Cervical Screening Program
Sep 9, 2025, 16:22 PM -
International Reference Pricing (IRP) Analysis for Original Medicines in Türkiye in 2024
Sep 9, 2025, 16:22 PM -
Unlocking the Value of RSV Adult Vaccination With Adjuvanted RSVpreF3 Vaccine in Spain: A Return on Investment Analysis Using an Integrated Actuarial Macroeconomic Model
Sep 9, 2025, 16:22 PM -
Maintaining Orphan Drug Status at the Time of Drug Approval in European Economic Area (EEA): European Union (EU) Plus Iceland and Norway From 2015 to 2025
Sep 9, 2025, 16:22 PM -
Is NICE’s Proportionate Approach Achieving Its Objective: Analysis of Time to Access for Cost Comparison vs. Single Technology Appraisal
Sep 9, 2025, 16:22 PM -
Analysis of the Epidemiological Disease Burden of Endometriosis in Hungary Based on Data From the Global Burden of Disease Study
Sep 9, 2025, 16:22 PM
